Last reviewed · How we verify
Avidekel oil
Avidekel oil is a cannabis-based medication that works by interacting with the body's endocannabinoid system.
Avidekel oil is a cannabis-based medication that works by interacting with the body's endocannabinoid system. Used for Treatment of spasticity in multiple sclerosis.
At a glance
| Generic name | Avidekel oil |
|---|---|
| Also known as | Avidekel cannabis oil |
| Sponsor | Wolfson Medical Center |
| Drug class | cannabinoid |
| Target | CB1 and CB2 receptors |
| Modality | Small molecule |
| Therapeutic area | Pain management |
| Phase | Phase 2 |
Mechanism of action
Avidekel oil contains a unique blend of cannabinoids, including CBD and THC, which have been shown to have anti-inflammatory and pain-relieving properties. The exact mechanism of action is not fully understood, but it is thought to involve the activation of cannabinoid receptors in the body, leading to a range of therapeutic effects.
Approved indications
- Treatment of spasticity in multiple sclerosis
Common side effects
- Dizziness
- Nausea
- Fatigue
Key clinical trials
- The Effect of Cannabis on Dementia Related Agitation and Aggression (PHASE2)
- Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis Suppurativa (PHASE2)
- The Effects of Cannabis on Dystonia and Spasticity on Pediatric Patients (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |